Name: Follicular Thyroid Cancer Drug Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4090
Price: 4350 USD
Availability: InStock

Follicular Thyroid Cancer Drug Market Size Share and Forecast 2023-2030

Follicular Thyroid Cancer Drug Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>Methodology and Scope

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary
	<ol>
		<li>Market Snippet by Drug Type</li>
		<li>Market snippet by Treatment Type</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing incidence of Thyroid Cancer cases</li>
				<li>Increased treatment and Effective Drug approvals</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Few drugs product recalls</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>By Drug Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Attractiveness Index, By Drug Type</li>
		</ol>
		</li>
		<li>Cabozantinib *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Lenvatinib and sorafenib</li>
		<li>Selpercatinib</li>
		<li>Larotrectinib and entrectinib</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Treatment Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Attractiveness Index, By Treatment Type</li>
		</ol>
		</li>
		<li>Surgery *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Radioactive Iodine drugs</li>
		<li>External beam Radiotherapy</li>
		<li>Thyroxin Treatment</li>
		<li>Chemotherapy</li>
	</ol>
	</li>
	<li>By Distribution channels
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channels</li>
			<li>Market Attractiveness Index, By Distribution channels</li>
		</ol>
		</li>
		<li>Hospital Pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Retail Pharmacies</li>
		<li>Online Pharmacies</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Pfizer*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Novartis AG.,</li>
		<li>GlaxoSmithKline Plc.,</li>
		<li>AstraZeneca.,</li>
		<li>Exelixis Inc,</li>
		<li>Celgene Corporation,</li>
		<li>Bayer AG,</li>
		<li>Eisai Co., Ltd,</li>
		<li>Merck &amp; Co.,</li>
		<li>Teva Pharmaceuticals.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>DataM Intelligence
	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables&nbsp;

Table 1 Global Follicular Thyroid Cancer Market Value, By Drug Type, 2021, 2025 &amp; 2029($ Million)

Table 2 Global Follicular Thyroid Cancer Market Value, By Treatment Type, 2021, 2025 &amp; 2029($ Million)

Table 3 Global Follicular Thyroid Cancer Market Value, By Distribution Channel, 2021, 2025 &amp; 2029($ Million)

Table 4 Global Follicular Thyroid Cancer Market Value, By Region, 2021, 2025 &amp; 2029($ Million)

Table 5 Global Follicular Thyroid Cancer Market Value, By Drug Type, 2021, 2025 &amp; 2029($ Million)

Table 6 Global Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 7 Global Follicular Thyroid Cancer Market Value, By Treatment Type, 2021, 2025 &amp; 2029($ Million)

Table 8&nbsp;&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 9 Global Follicular Thyroid Cancer Market Value, By Distribution Channel, 2021, 2025 &amp; 2029($ Million)

Table 10&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 11&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Value, By Region, 2021, 2025 &amp; 2029($ Million)

Table 12&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Value, By Region, 2019-2029 ($ Million)

Table 13&nbsp;&nbsp;&nbsp; North America Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 14&nbsp;&nbsp;&nbsp; North America Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 15&nbsp;&nbsp;&nbsp; North America Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 16&nbsp;&nbsp;&nbsp; North America Follicular Thyroid Cancer Market Value, By Country, 2019-2029 ($ Million)

Table 17&nbsp;&nbsp;&nbsp; South America Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 18&nbsp;&nbsp; South America Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 19&nbsp;&nbsp;&nbsp; South America Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 20&nbsp;&nbsp; South America Follicular Thyroid Cancer Market Value, By Country, 2019-2029 ($ Million)

Table 21&nbsp;&nbsp;&nbsp; Europe Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 22&nbsp;&nbsp; Europe Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 23&nbsp;&nbsp; Europe Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 24&nbsp;&nbsp; Europe Follicular Thyroid Cancer Market Value, By Country, 2019-2029 ($ Million)

Table 25&nbsp;&nbsp; Asia-Pacific Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 26&nbsp;&nbsp; Asia-Pacific Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 27&nbsp;&nbsp; Asia-Pacific Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 28&nbsp;&nbsp; Asia-Pacific Follicular Thyroid Cancer Market Value, By Country, 2019-2029 ($ Million)

Table 29&nbsp;&nbsp; Middle East &amp; Africa Follicular Thyroid Cancer Market Value, By Drug Type, 2019-2029 ($ Million)

Table 30&nbsp;&nbsp; Middle East &amp; Africa Follicular Thyroid Cancer Market Value, By Treatment Type, 2019-2029 ($ Million)

Table 31&nbsp;&nbsp;&nbsp; Middle East &amp; Africa Follicular Thyroid Cancer Market Value, By Distribution Channel, 2019-2029 ($ Million)

Table 32&nbsp;&nbsp; Pfizer Inc: Overview

Table 33&nbsp;&nbsp; Pfizer Inc: Product Portfolio

Table 34&nbsp;&nbsp; Pfizer Inc: Key Developments

Table 35&nbsp;&nbsp; Novartis AG: Overview

Table 36&nbsp;&nbsp; Novartis AG: Product Portfolio

Table 37&nbsp;&nbsp; Novartis AG: Key Developments

Table 38&nbsp;&nbsp; Merck &amp; Co: Overview

Table 39&nbsp;&nbsp; Merck &amp; Co: Product Portfolio

Table 40&nbsp;&nbsp; Merck &amp; Co: Key Developments

Table 41&nbsp;&nbsp;&nbsp; AstraZeneca: Overview

Table 42&nbsp;&nbsp; AstraZeneca: Product Portfolio

Table 43&nbsp;&nbsp; AstraZeneca: Key Developments

Table 44&nbsp;&nbsp; GlaxoSmithKline Plc: Overview

Table 45&nbsp;&nbsp; GlaxoSmithKline Plc: Product Portfolio

Table 46&nbsp;&nbsp; GlaxoSmithKline Plc: Key Developments

Table 47&nbsp;&nbsp; Exelixis Inc: Overview

Table 48&nbsp;&nbsp; Exelixis Inc: Product Portfolio

Table 49&nbsp;&nbsp; Exelixis Inc: Key Developments

Table 50&nbsp;&nbsp; Celgene Corporation: Overview

Table 51&nbsp;&nbsp;&nbsp; Celgene Corporation: Product Portfolio

Table 52&nbsp;&nbsp; Celgene Corporation: Key Developments

Table 53&nbsp;&nbsp; Teva Pharmaceuticals: Overview

Table 54&nbsp;&nbsp; Teva Pharmaceuticals: Product Portfolio

Table 55&nbsp;&nbsp; Teva Pharmaceuticals: Key Developments

Table 56&nbsp;&nbsp; Eisai Co., Ltd: Overview

Table 57&nbsp;&nbsp; Eisai Co., Ltd: Product Portfolio

Table 58&nbsp;&nbsp; Eisai Co., Ltd: Key Developments

Table 59&nbsp;&nbsp; Bayer AG: Overview

Table 60&nbsp;&nbsp; Bayer AG: Product Portfolio

Table 61&nbsp;&nbsp;&nbsp; Bayer AG: Key Developments

List of Figures

Figure 1&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 2&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 3&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 4&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Share, By Region, 2021 &amp; 2029(%)

Figure 5&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 6&nbsp;&nbsp;&nbsp; Global Follicular Thyroid Cancer Market Y-o-Y Growth, By Drug Type, 2021-2029 (%)

Figure 7&nbsp;&nbsp;&nbsp; Cabozantinib: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 8&nbsp;&nbsp;&nbsp; Lenvatinib and sorafenib: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 9&nbsp;&nbsp;&nbsp; Selpercatinib: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 10&nbsp; Larotrectinib and entrectinib: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 11&nbsp; Others: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 12&nbsp; Global Follicular Thyroid Cancer Market Y-o-Y Growth, By Treatment Type, 2021-2029 (%)

Figure 13&nbsp; Surgery: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 14&nbsp; Radioactive Iodine drugs: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 15&nbsp; Chemotherapy: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 16&nbsp; External beam radiotherapy: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 17&nbsp; Thyroxine Treatment: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 18&nbsp; Global Follicular Thyroid Cancer Market Y-o-Y Growth, By Distribution Channel, 2021-2029 (%)

Figure 19&nbsp; Hospital Pharmacies: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 20 Retail Pharmacies: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 21&nbsp; Online Pharmacies: Global Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 22 Global Follicular Thyroid Cancer Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 23 North America Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 24 North America Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 25 North America Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 26 North America Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 27&nbsp; North America Follicular Thyroid Cancer Market Share, By Country, 2021 &amp; 2029(%)

Figure 28 South America Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 29 South America Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 30 South America Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 31&nbsp; South America Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 32 South America Follicular Thyroid Cancer Market Share, By Country, 2021 &amp; 2029(%)

Figure 33 Europe Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 34 Europe Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 35 Europe Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 36 Europe Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 37&nbsp; Europe Follicular Thyroid Cancer Market Share, By Country, 2021 &amp; 2029(%)

Figure 38 Asia-Pacific Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 39 Asia-Pacific Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 40 Asia-Pacific Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 41&nbsp; Asia-Pacific Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 42 Asia-Pacific Follicular Thyroid Cancer Market Share, By Country, 2021 &amp; 2029(%)

Figure 43 Middle East &amp; Africa Follicular Thyroid Cancer Market Value, 2019-2029 ($ Million)

Figure 44 Middle East &amp; Africa Follicular Thyroid Cancer Market Share, By Drug Type, 2021 &amp; 2029(%)

Figure 45 Middle East &amp; Africa Follicular Thyroid Cancer Market Share, By Treatment Type, 2021 &amp; 2029(%)

Figure 46 Middle East &amp; Africa Follicular Thyroid Cancer Market Share, By Distribution Channel, 2021 &amp; 2029(%)

Figure 47&nbsp; Pfizer Inc: Financials

Figure 48 Novartis AG: Financials

Figure 49 Merck &amp; Co: Financials

Figure 50 AstraZeneca: Financials

Figure 51&nbsp; GlaxoSmithKline Plc: Financials

Figure 52 Exelixis Inc: Financials

Figure 53 Celgene Corporation: Financials

Figure 54 Teva Pharmaceuticals: Financials

Figure 55 Eisai Co., Ltd: Financials

Figure 56 Bayer AG: Financials